Loading...
XSHG
600771
Market cap1.32bUSD
Dec 05, Last price  
19.04CNY
1D
-0.10%
1Q
-5.37%
Jan 2017
-20.29%
Name

GuangYuYuan Chinese Herbal Medicn Co Ltd

Chart & Performance

D1W1MN
XSHG:600771 chart
P/E
125.18
P/S
7.63
EPS
0.15
Div Yield, %
Shrs. gr., 5y
0.28%
Rev. gr., 5y
0.07%
Revenues
1.22b
-4.87%
549,202,754540,371,537531,192,256307,725,961257,641,102229,820,920228,929,042260,653,806268,111,311354,154,540428,436,063936,993,2281,168,684,8141,618,764,0101,217,097,4711,109,430,046854,223,148994,694,7901,284,015,7511,221,426,276
Net income
74m
-17.35%
35,305,18312,622,3300331,248,9820193,629,030299,716,482355,571,479036,646,3832,030,309122,810,065236,804,798374,108,052130,068,24532,003,0010090,078,56574,453,018
CFO
112m
-47.85%
290,027,704178,973,1620035,171,4450000000000081,368,872253,426,205215,499,935112,391,418
Dividend
Jul 30, 20030.068 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional and fine Chinese medicines, as well as health wines. It provides its products in the form of pills, powders, tablets, hard capsules, granules, oral liquids, decoctions, and wines. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its name to GuangYuYuan Chinese Herbal Medicine Co., Ltd. in July 2013. GuangYuYuan Chinese Herbal Medicine Co., Ltd. is based in Xi'an, China.
IPO date
Nov 05, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT